Feedback from AGM please Unfortunately I didn’t have the time to attend this year. Nice move to appoint Liberum- we’re now a small fish swimming with the big fish. It wouldn’t take much additional buying interest for us to have a really good growth spurt! IMO the most important thing is in this sector is the chemistry- getting a new drug approved in the most highly regulated industry in the world is a very technical undertaking. The FUM board in my opinion is really strong in this remit. They’ve made a few errors on the business end and we’ve paid the price by way of market confidence taking our stock price as low as the single digits. However, I believe they’ve learnt from these errors and the market is now starting to realise that where we need to be strong, we are strong, and the previous negative perception is pivoting. I remain convinced that you won’t find a better Risk:Reward ratio anywhere in any sector in any UK market. Let’s see what unfolds between now and the end of this year… GLA
Dare we Dream? I know it really could be anything, I never think it’s worth trying to guess to be honest. We’ve got to remember anything could happen between now and December. Have to say it is a shame about the TPR delay but I mean it’s all going to come down to the end of the year anyway. In the last RNS they stated ‘we continue discussions with a number of interested commercial partners for the out-licensing of MED2005.’ I’m sure if they got the right offer they’d take it but saying that if they’re confident about positive phase 3 results (which I think they are), they’re better holding out. Hopefully the SP will hold out strong the rest of this week, we’ll have to wait and see.
Feedback from AGM please Feedback from AGM please for anyone that attended. I’m out of the country so was unable to attend. FX?? Tony??? Much appreciated
Dare we Dream? Futura Medical doesn’t have the means to produce a product and market a product by itself. So I’ve used the projected figures and assumed a 20 percent royalty rate based on phase 3 data being available. I arrive at a price between £1.80 to £3.60 per share for MED that would be attributable to FUM. But what do I know. Could be anything to be honest!!
Dare we Dream? Proactiveinvestors UK Futura Medical mulling fast-track European submission for lead drug candidate Futura Medical PLC (LON:FUM) - Depending on the read-out from current study, it may opt to submit the results from just one phase III trial in Europe. But at this stage it is only considering this option
Dare we Dream? That would mean there was an initial valuation of 650 million on the table during negotiations, as Barder said the derisking after phase 3 would increase the value with 50%… I think they would have taken the deal immediately even @250-400 million! My biggest fear, even with a decent outcome after ph 3 is that no big pharmaco will pay top dollar…I am guessing a valuation of 400 million dollar in total or $2 dollar per share after excellent ph 3 trials. But we will found out very soon…hopefully big Pharma Co’s are involved and not just small players that will just pay small upfront and bigger royalties but don’t have a big marketing machine to develop the widespread sale of the gel. A bit disappointed by the current TPR update and progress…we need this news to go towards the Liberum’s first 60p target price, before the readout of phase 3 trials.
Dare we Dream? It’s great to dream. I can see Barder at the negotiating table, like Dr Evil, demanding “one million dollars” , as GSK, Bayer etc fall about hysterically…
Dare we Dream? Whilst researching potential valuations I came across the name “Joseph Edelman”, portfolio manager at Perceptive Advisors and apparently widely regarded as the greatest biotech investor of all time. So he typically places a 3 x peak sales multiple on potential drug candidates although in some cases he has applied multiples of 6x or more. So I know and we all know MEDs projected peak sales amount to a billion dollars. If we assume 500 million dollars for now and just use a multiple of 3, this means if it’s sold off it should command 1.5 billion dollars . If we discount this further by only assuming a multiple of 2, we get a billion dollars. Surely not???Dare we dream??
The conundrum I’m one of those 100,000 at An average of 55p! 5 years!
The conundrum Let’s hope so, have to say it’s looking really good at the moment. Recruitment completed on schedule and on budget. TPR update should be soon. Management looking really confident. We just need MED to back this up with some positive results at the end of the year. It all comes down to that really. You might be wishing it was all your portfolio by the end of the year Pharmatom Anyway good luck everyone! (Especially the long term holders who’ve suffered over the years)
The conundrum Are we on the road towards 60p? #excitingtimes! Only problem is that FUM is now more than 50% of my entire portfolio!!! #sleeplessnights
The conundrum Hope all of us long term share holders (and the more recent ones) have a bright future ahead of ourselves, and we look back at some of the old posts and chuckle to ourselves. The good old days of conspiracy theories will soon be replaced with some solid news and we’ll all be much better off (fingers crossed) Good luck all
The conundrum You can’t complain today
The conundrum Okay, just making sure I hadn’t missed anything as only news I’d seen should already have been priced in. Nice to see the rise continue prior to the AGM. Would be good to see it close above 30p.
The conundrum The FOMO effect, trial is proceeding faster than anticipated, Ken is sounding rather extremely bullih…but hey the rise today is already answering my question it seems…